Quantification of the survival benefit of early versus deferred cystectomy in high-risk non-muscle invasive bladder cancer (T1 G3)

World Journal of Urology

Volumn 27, Issue 3, 2009, Pages 347-351

  Hautmann, Richard E ^a   Volkmer, Bjoern G ^a   Gust, Kilian ^a  

^a UNIVERSITY OF ULM   (Germany)

Author keywords

Bladder carcinoma; Deferred cystectomy; Early cystectomy; Non muscle invasive bladder cancer; T1 G3 urothelial cancer

Indexed keywords

ADULT; AGED; BLADDER TUMOR; CANCER INVASION; CANCER STAGING; COMPARATIVE STUDY; CYSTECTOMY; FEMALE; HUMAN; MALE; MIDDLE AGED; MORTALITY; PATHOLOGY; REVIEW; RISK FACTOR; SURVIVAL RATE;

ADULT; AGED; AGED, 80 AND OVER; CYSTECTOMY; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM STAGING; RISK FACTORS; SURVIVAL RATE; URINARY BLADDER NEOPLASMS; YOUNG ADULT;

EID: 67349131272     PISSN: 07244983     EISSN: 14338726     Source Type: Journal    
DOI: 10.1007/s00345-009-0402-4     Document Type: Review

References (21)

1. Lambert EH, Pierorazio PM, Olsson CA, Benson MC, McKiernan JM, Poon S (2007) The increasing use of intravesical therapies for stage T1 bladder cancer coincides with decreasing survival after cystectomy. BJU Int 100:33-36. doi: 10.1111/j.1464-410X.2007.06912.x
2. Malavaud B (2004) T1 G3 bladder tumours: The case for radical cystectomy. Eur Urol 45:406-410. doi: 10.1016/j.eururo.2003.11.007
3. Evans CP, Busby JE (2003) The management of stage T1 grade 3 transitional cell carcinoma of the bladder. BJU Int 92:345-348. doi: 10.1046/j.1464-410X.2003.04357.x
4. Stein JP, Penson DF (2008) Invasive T1 bladder cancer: Indications and rationale for radical cystectomy. BJU Int 102:270-275. doi: 10.1111/ j.1464-410X.2008.07743.x
5. Denzinger S, Fritsche HM, Otto W, Blana A, Wieland WF, Burger M (2008) Early versus deferred cystectomy for initial high-risk pT1 G3 urothelial carcinoma of the bladder: Do risk factors define feasibility of bladder-sparing approach? Eur Urol 53:146-152. doi: 10.1016/ j.eururo.2007.06.030
6. Andius P, Johansson SL, Holmäng S (2007) Prognostic factors in stage T1 bladder cancer: Tumor pattern (solid of papillary) and vascular invasion more important than depth of invasion. Urology 70:758-762. doi: 10.1016/j.urology.2007.06.638
7. Kamat AM, Gee JR, Dinney CPN, Grossmann HB, Swanson DA, Millikan RE, Detry MA, Robinson TL, Pisters LL (2006) The case for early cystectomy in the treatment of nonmuscle invasive micropapillary bladder carcinoma. J Urol 175:881-885. doi: 10.1016/S0022-5347(05)00423-4
8. Sylvester RJ, van der Meijden APM, Oosterlinck W, Witjes JA, Bouffioux C, Denis L, Newling DWW, Kurth K (2006) Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: A combined analysis of 2,596 patients from seven EORTC trials. Eur Urol 49:466-477. doi: 10.1016/j.eururo.2005.12.031
9. Smits G, Schaafsma E, Kiemeney L, Caris C, Debruyne F, Witjes JA (1998) Microstaging of pT1 transitional call carcinoma of the bladder: indentification of subgroups with distinct risks of progression. Urology 52:1009-1014. doi: 10.1016/S0090-4295(98)00374-4
10. Herr HW, Donat SM (2006) A re-staging transurethral resection predicts early progression of superficial bladder cancer. BJU Int 97:1194-1198. doi: 10.1111/j.1464-410X.2006.06145.x
11. Thalmann GN, Markwalder R, Shahin O, Burkhard FC, Hochreiter WW, Studer UE (2004) Primary T1 G3 bladder cancer: Organ preserving approach or immediate cystectomy? J Urol 172:70-75. doi: 10.1097/ 01.ju.0000132129.87598.3b
12. Schrier BP, Hollander MP, van Rhijn BWG, Kiemeney LA, Witjes JA (2004) Prognosis of muscle-invasive bladder cancer: Difference between primary and progressive tumours and implications for therapy. Eur Urol 45:292-296. doi: 10.1016/j.eururo.2003.10.006
13. Jakse G, Algaba F, Malmström PU, Oosterlinck W (2004) A second-look TUR in T1 transitional cell carcinoma: Why? Eur Urol 45:539-546. doi: 10.1016/j.eururo.2003.12.016
14. Serretta V, Ruggirello A, Dispensa N, Allegro R, Darvinio Melloni FA (2008) Multiplicity and history have a detrimental effect on survival of patients with T1 G3 bladder tumors selected for conservative treatment. J Urol 180:886-891. doi: 10.1016/j.juro.2008.05.013
15. Konety BR (2006) Molecular markers in bladder cancer: A critical appraisal. Urol Oncol 24:326-337. doi: 10.1016/j.urolonc.2005.11.023
16. Dutta SC, Smith JA Jr, Shappell SB, Coffey CS, Chang SS, Cookson MS (2001) Clinical understaging of high-risk nonmuscle invasive urothelial carcinoma treated with radical cystectomy. J Urol 166:490-493. doi: 10.1016/S0022-5347(05)65969-1
17. Fahmy NM, Mahmud S, Aprikian AG (2006) Delay in the surgical treatment of bladder cancer and survival: Systematic review of the literature. Eur Urol 50:1176-1182. doi: 10.1016/j.eururo.2006.05.046
18. Chang SS, Hassan JM, Cookson MS, Wells N, Smith JA Jr (2003) Delaying radical cystectomy for muscle invasive bladder cancer results in worse pathological stage. J Urol 170:1085-1087. doi: 10.1097/ 01.ju.0000086828.26001.ca
19. Shahin O, Thalmann GN, Rentsch C, Mazzucchelli L, Studer UE (2003) A retrospective analysis of 153 patients treated with or without intravesical bacillus Calmette-Guerin for primary stage T1 grade 3 bladder cancer: Recurrence, progression and survival. J Urol 169:96-100. doi: 10.1016/S0022-5347(05)64044-X
20. Raj GV, Herr H, Serio AM, Donat SM, Bochner BH, Vickers AJ, Dalbagni G (2007) Treatment paradigm shift may improve survival of patients with high-risk superficial bladder cancer. J Urol 177:1283-1286. doi: 10.1016/ j.juro.2006.11.090
21. Wiesner C, Pfitzenmaier J, Faldum A, Gillitzer R, Melchior SW, Thüroff JW (2005) Lymph node metastases in non-muscle invasive bladder cancer are correlated with the number of transurethral resections and tumour upstaging at radical cystectomy. BJU Int 95:301-305. doi: 10.1111/j.1464-410X.2005.05287.x